Skip to main content
Clinical Trials/JPRN-UMIN000044009
JPRN-UMIN000044009
Recruiting
未知

Comparison of intraoperative intravenous anesthetic agents (propofol and remimazolam) in patients with lung cancer: prospective cohort study - Comparison of intravenous anesthetic agents in patients with lung cancer: prospective cohort study

Department of anesthesiology and pain medicine, Juntendo University0 sites150 target enrollmentApril 25, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
ung cancer patients
Sponsor
Department of anesthesiology and pain medicine, Juntendo University
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 25, 2021
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of anesthesiology and pain medicine, Juntendo University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients whose consent was not obtained. Patients who are taking immunosuppressive drugs or steroids. Patients who have already received chemoradiation therapy. Simultaneous bilateral surgery. Patients with autoimmune diseases such as collagen diseases. Cardiac disease of NYHA III degree or higher. Respiratory dysfunction with a VC or FEV1 of less than 50%. Pulmonary hypertension with mean pulmonary artery pressure of 30 mmHg or more. Highly obese patients with BMI greater than 30\. Severe hepatic or renal dysfunction. Patients with allergy to propofol or benzodiazepine anesthetics. Other patients who are judged by the principal investigator to be inappropriate as research subjects.

Outcomes

Primary Outcomes

Not specified

Similar Trials